Sorrento Therapeutics, Inc. 13D and 13G filings for Celularity Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-10-05 5:22 pm Sale |
2023-09-29 | 13G | Celularity Inc. CELU |
Sorrento Therapeutics Inc. SRNEQ |
505,043 2.600% |
-1,537,170 (-75.27%) |
Filing |
| 2021-07-23 06:02 am Purchase |
2021-07-16 | 13G | Celularity Inc. CELU |
Sorrento Therapeutics Inc. SRNEQ |
2,042,212 16.700% |
2,042,212 (New Position) |
Filing |